227 related articles for article (PubMed ID: 32974773)
1. The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis.
Pereira PL; Iezzi R; Manfredi R; Carchesio F; Bánsághi Z; Brountzos E; Spiliopoulos S; Echevarria-Uraga JJ; Gonçalves B; Inchingolo R; Nardella M; Pellerin O; Sousa M; Arnold D; de Baère T; Gomez F; Helmberger T; Maleux G; Prenen H; Sangro B; Zeka B; Kaufmann N; Taieb J
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):50-62. PubMed ID: 32974773
[TBL] [Abstract][Full Text] [Related]
2. A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL.
Pereira PL; Arnold D; de Baère T; Gomez F; Helmberger T; Iezzi R; Maleux G; Prenen H; Sangro B; Nordlund A; Zeka B; Bauer R; Kaufmann N; Pellerin O; Taieb J
Dig Liver Dis; 2020 Aug; 52(8):857-861. PubMed ID: 32620520
[TBL] [Abstract][Full Text] [Related]
3. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
Martin RC; Robbins K; Tomalty D; O'Hara R; Bosnjakovic P; Padr R; Rocek M; Slauf F; Scupchenko A; Tatum C
World J Surg Oncol; 2009 Nov; 7():80. PubMed ID: 19886993
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
Huppert P; Wenzel T; Wietholtz H
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
Ishikawa T; Imai M; Sato R; Jimbo R; Kobayashi Y; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
Anticancer Res; 2023 Aug; 43(8):3647-3651. PubMed ID: 37500124
[TBL] [Abstract][Full Text] [Related]
7. Safety, Feasibility and Technical Considerations from a Prospective, Observational Study-CIREL: Irinotecan-TACE for CRLM in 152 Patients.
Helmberger T; Lucatelli P; Pereira PL; Gjoreski A; Jovanoska I; Bansaghi Z; Spiliopoulos S; Carchesio F; Arnold D; Baierl A; Zeka B; Kaufmann NC; Taieb J; Iezzi R
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294499
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases.
Zhao G; Liu S; Zhang Y; Zhao T; Wang R; Bian J; Wu J; Zhou J
Ir J Med Sci; 2022 Jun; 191(3):1139-1145. PubMed ID: 34264426
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients.
Ngo A; von Stempel C; Corbo B; Bandula S; Shiu KK; Raja J; Hague J; Evans J; Kibrya N
Cardiovasc Intervent Radiol; 2019 Jul; 42(7):979-990. PubMed ID: 31044294
[TBL] [Abstract][Full Text] [Related]
10. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
[TBL] [Abstract][Full Text] [Related]
11. Safety and Tolerability of Topotecan-Eluting Radiopaque Microspheres for Hepatic Chemoembolization in a Rabbit Preclinical Model.
Mikhail AS; Levy EB; Krishnasamy VP; Woods DL; Esparza-Trujillo JA; Bakhutashvili I; Banovac F; Wakim PG; Negussie AH; Tang Y; Henman A; Willis SL; Karanian JW; Pritchard WF; Lewis AL; Wood BJ
Cardiovasc Intervent Radiol; 2020 Dec; 43(12):1918-1924. PubMed ID: 32803282
[TBL] [Abstract][Full Text] [Related]
12. Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30-60 μm Microspheres Loaded with Irinotecan.
Malagari K; Kiakidis T; Moschouris H; Charokopakis A; Vergadis C; Alevisopoulos N; Kartsouni V; Panagiotou I; Pellerin O; Glantzounis G; Filippiadis DK; Emmanouil E; Tsavaris N; Psarros G; Delicha E; Kelekis N
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):880-890. PubMed ID: 37337059
[TBL] [Abstract][Full Text] [Related]
13. Does Bead Size Affect Patient Outcome in Irinotecan-Loaded Beads Chemoembolization Plus Systemic Chemotherapy Regimens for Liver-Dominant Colorectal Cancer? Results of an Observational Study.
Boeken T; Moussa N; Pernot S; Abed A; Dean C; Taieb J; Sapoval M; Pellerin O
Cardiovasc Intervent Radiol; 2020 Jun; 43(6):866-874. PubMed ID: 32103303
[TBL] [Abstract][Full Text] [Related]
14. Survival of Patients with Colorectal Liver Metastases after Transarterial Chemoembolization Using Irinotecan-Eluting Microspheres: A Single-Center Retrospective Analysis Comparing RECIST 1.1 and Choi Criteria.
Maraj T; Mirrahimi A; Dey C
J Vasc Interv Radiol; 2023 Jun; 34(6):983-990.e1. PubMed ID: 36775014
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
[TBL] [Abstract][Full Text] [Related]
16. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
17. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.
Bower M; Metzger T; Robbins K; Tomalty D; Válek V; Boudný J; Andrasina T; Tatum C; Martin RC
HPB (Oxford); 2010 Feb; 12(1):31-6. PubMed ID: 20495642
[TBL] [Abstract][Full Text] [Related]
18. Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.
Fereydooni A; Letzen B; Ghani MA; Miszczuk MA; Huber S; Chapiro J; Schlachter T; Geschwind JF; Georgiades C
J Vasc Interv Radiol; 2018 Dec; 29(12):1646-1653.e5. PubMed ID: 30337148
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Safety of CT-Guided High-Dose-Rate Brachytherapy Combined with Transarterial Chemoembolization Using Irinotecan-Loaded Microspheres for the Treatment of Large, Unresectable Colorectal Liver Metastases.
Collettini F; Jonczyk M; Meddeb A; Wieners G; Geisel D; Schnapauff D; Gebauer B
J Vasc Interv Radiol; 2020 Feb; 31(2):315-322. PubMed ID: 31537409
[TBL] [Abstract][Full Text] [Related]
20. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
